ACIC Pharma Division
In response to customer requests, ACIC has established a Pharma Division to oversee the development and manufacturing activities of finished dosage forms.
With particular expertise in EU dossier conversion, technology/site transfers, and custom manufacturing/development, ACIC is a truly integrated partner.
ACIC can assist manufacturing facilities, whether already FDA inspected or in the process of triggering inspection.
ACIC can provide a variety of manufacturing technologies to customers including:
- Global Regulatory Support
- Marketing and Sales
- Manufacturing:
- Tablets/Capsules
- Semi-Solids
- Small Volume Parenterals
- Large Volume Parenterals
- Liquid Injectables
- Lyophilization
- Sterile Powder Filling
- Topicals
- Blow-Fill-Seal
ACIC has dedicated sterile and non-sterile facilities for the production of:
- Pen-Ems
- Cephalosporins
- Penicillins
- High Potency drug products
- Biosimilars
ACIC can provide the following services to customers:
Formulation R&D
- Literature surveys and comparative brand studies
- Raw material sourcing (API, excipients)
- Production of trial batches
- Testing of physical and core parameters
- Stability testing
Method Development & Validation of Analytical Methods
- API characterization
- Excipients testing
- Reference product characterization
- Method validation
- Cleaning validation
Manufacture of Drug Product
- Drug product in-process testing
- Finished product release testing
- Cleaning verification
- Packaging
- Stability testing
Technology Transfers
Clinical and Bio-analytical support
- Pilot and pivotal BE studies
- Dissolution Testing
In-house Global Regulatory/Technical support
- Electronic CTD format dossiers
- ANDA, NDA, ANDS, MA, etc.
Please contact us to learn more about the drug products/dossiers we have available in your region and to discuss your project further.
Mr. Luciano Calenti
President, ACIC
Tel: 001-519-751-3668
|
|
|
Dr. Akis Makryaleas
President, ACIC Europe
European Business Development
API and Pharma (Dosage)
Tel: +357-25-578696
Fax: +357-25-563980
|
|
|
|
|